e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Treating bronchiectasis in respiratory patients
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Bacterial etiology of exacerbations of non-cystic fibrosis bronchiectases in young patients
N. Rutenko, S. Baydurin, A. Baygenzhin (Astana, Kazakhstan)
Source:
Annual Congress 2013 –Treating bronchiectasis in respiratory patients
Session:
Treating bronchiectasis in respiratory patients
Session type:
Oral Presentation
Number:
4649
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Rutenko, S. Baydurin, A. Baygenzhin (Astana, Kazakhstan). Bacterial etiology of exacerbations of non-cystic fibrosis bronchiectases in young patients. Eur Respir J 2013; 42: Suppl. 57, 4649
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Investigations of broncho-alveolar lavage in children with asthma, bronchiectasis and cystic fibrosis
Source: International Congress 2015 – Paediatric bronchology
Year: 2015
Value of bronchoalveloar lavage (BAL) in management of lung infections in adult cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment
Year: 2015
The dynamics of IV-type collagen contens in balf of patients with chronic bronchitis and chronic bronchitis complicated with secondary bronchiectasis
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013
Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Bronchoalveolar lavage
Source: Eur Respir Mon; 2010: 48: 59–72
Year: 2010
Usefulness of bronchoalveolar lavage in the diagnosis of desquamative interstitial pneumonia
Source: International Congress 2014 – ILDs 2
Year: 2014
Biomarkers of fibroproliferative healing in fibrosing idiopathic interstitial pneumonias
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Endobronchial biopsies in children with protracted bacterial bronchitis
Source: Annual Congress 2013 –Paediatric bronchology
Year: 2013
Refractory severe asthma: Is presence of aspergillus in broncho-alveolar lavage significant?
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Year: 2015
Inflammatory markers in serum and lavage fluid in young adult’s patients with postinfectious bronchiolitis obliterans
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013
Cathelicidin (LL-37) ve human β2 defensin levels in bronchoalveolar fluid of pediatric patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Paediatric pulmonary infections
Year: 2015
Bronchoalveolar lavage in idiopathic pulmonary fibrosis
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017
Impact of lymphocyte differential count in BALF on the mortality of patients with acute exacerbation of idiopathic chronic fibrosing interstitial pneumonia
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Clinical and immunological parameters in patients with newly diagnosed sarcoidosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
Colonization of bacteria after lung transplantation in cystic fibrosis (CF) patients occurs early but does not impact survival
Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment
Year: 2015
BAL findings in desquamative interstitial pneumonia (DIP) and other idiopathic interstitial pneumonia (IIP)
Source: International Congress 2014 – ILDs 4
Year: 2014
Bronchial wash/lavage and etiologic diagnosis on immunocompromised patients
Source: Annual Congress 2013 –Comfort, safety and effectiveness of bronchoscopy
Year: 2013
Sputum bacterial concentrations and exacerbations of non cystic fibrosis bronchiectasis
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Galactomannan in the bronchoalveolar lavage for diagnosing invasive fungal disease
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept